"Atrium Health Cleveland in Shelby is a 241-bed hospital serving greater Cleveland County, NC, and the surrounding region."

During the past decade, Atrium Health Cleveland/LCI-Cleveland conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atrium Health Cleveland/LCI-Cleveland" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "SWOG Cancer Research Network" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "NRG Oncology" with 3 trials sponsored and "Wake Forest University Health Sciences" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atrium Health Cleveland/LCI-Cleveland" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Atrium Health Cleveland/LCI-Cleveland" are "Breast Ductal Carcinoma In Situ" (2 trials), "Colon Adenocarcinoma" (2 trials), "Invasive Breast Carcinoma" (2 trials), "Prostate Cancer" (2 trials) and "Rectal Adenocarcinoma" (2 trials). Many other conditions were trialed in "Atrium Health Cleveland/LCI-Cleveland" in a lesser frequency.

Most popular intervention types in "Atrium Health Cleveland/LCI-Cleveland" are "Drug" (19 trials), "Other" (16 trials), "Biological" (9 trials), "Procedure" (8 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Paclitaxel" (5 trials), "Docetaxel" (4 trials), "Quality-of-Life Assessment" (4 trials) and "Trastuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Atrium Health Cleveland/LCI-Cleveland" are 22 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Atrium Health Cleveland/LCI-Cleveland". undefined are not yet recruiting, 5 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Atrium Health Cleveland/LCI-Cleveland, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atrium Health Cleveland/LCI-Cleveland, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".